PPT-The Opioid Epidemic and the Role of Naloxone

Katherine Wang PharmD The Center for Children and Women Greenspoint Conflict of Interest Disclosure The presenters planners reviewers including CME administrator of todays CME activity do not have any financial relationships or commercial interests to disclose. Alex . Walley. & Maya Doe-. Simkins. on behalf of prescribetoprevent.org. prescribetoprevent.org: . Jenny . Arnold, . PharmD. , . BCPS. Leo . Beletsky. , JD, . MPH. Alice . Bell, . LCSW. Sarah . John J. Faragon, Pharmacist, HIV Medicine. Regional Pharmacy Director, . NY/NJ AIDS Education and Training Center. Objectives. Describe the correlation between prescription drug abuse and the rate of opioid related overdose deaths. . for Peace Officers and EMTs . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . Narcan. ) Induced Pulmonary Edema. John Cunha, DO, FACOEP. Holy Cross Hospital. Oakland Park EMS Medical Director. Naloxone (. Narcan. ) Use. Used to reverse the respiratory depression effects of opioids. Aaron Kochar, J.D.. akochar@yahoo.com. Talk Takeaways. Indiana’s legal framework has been revised to promote widespread distribution of naloxone to all Hoosiers. Indiana Laws written to remove barriers. Mark . Peffer. Butler County Sheriff’s Office. Butler County . Naloxone. Manager. David’s Law-. Opioid. Overdose Reversal Act 139. Allows 1. st. Responders to possess and administer . Naloxone. Rebecca McDonald. National Addiction . Centre. King’s College London. Declarations. RM has undertaken an unpaid student industry placement with . Mundipharma. Research Ltd., with focus on the analysis of naloxone nasal spray formulations. . Please read the consent agreement in front of you and further instructions will be given on how to complete the pre-training survey. . . Remove . the “ID” number label and save it . – you’ll need this for today’s post-training survey, . October 24. th. ,. . 2016. Sarah Ruiz, . MSW. , . Naloxone Pilot Program, Massachusetts Department of Public Health. Alexander Walley,. MD, MSc, Medical Director, MDPH Opioid Overdose Prevention Pilot Program.  . Michael Lynch, MD. Assistant Professor of Emergency Medicine and Toxicology, University of Pittsburgh. Medical Director, Pittsburgh Poison Center. . 2017 US Overdose Deaths: >72,000. 1. Rapidly rising death rate due to potency, fentanyl analogues. Training of Trainers. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Agenda. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Understanding Opioids. NALOXONE (. Narcan. ®). Developed in the 1960s. Increased opioid use and abuse. Greater . variety of available opioids . Increased demand for naloxone. Opioid . competitive antagonist. Emergent overdose treatment in hospital and . MD., DA., DNB, Dip. Diab., PhD (physiology). Dip. Software based statistics- . IDRA, CUGRA . What are they ? . Minor changes in the structure of an opioid agonist. . convert the drug into an opioid antagonist at one or more of the opioid receptor sites . Trainer Name. location AND DATE. Learning objectives. By the end of the presentation, participants will:. Understand requirements of the Community-Based Naloxone Access Program Standing Order. Know what naloxone is and how to store, track and administer it.